<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000285990"><TermName>open label study</TermName><TermPronunciation>(OH-pen LAY-bel STUH-dee)</TermPronunciation><TermDefinition><DefinitionText>A type of study in which both the health providers and the patients are aware of the drug or treatment being given.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000710137" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;open label study&quot;" language="en" id="_3"/><MediaLink ref="CDR0000710138" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;estudio sin anonimato&quot;" language="es" id="_4"/><SpanishTermName>estudio sin anonimato</SpanishTermName><SpanishTermDefinition><DefinitionText>Tipo de estudio en el que tanto los proveedores de la salud como los pacientes conocen el medicamento o el tratamiento que se administra.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-02-21</DateFirstPublished></GlossaryTerm>
